10-Q Filing

Silo Pharma, Inc. CIK: 1514183 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001213900-13-002541`
Period End Date	20130331
Filing Date	20130515
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	gldsw-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 15 Cash Flow Statement 41 Stockholders Equity 21

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$279.00	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`Cash`	$10.10K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$279.00	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$10.10K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total Assets	`Assets`	$10.10K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$279.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.73M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.69K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.73M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$33.11K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$5.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$20.00K	USD	Point-in-time
Interest payable	`InterestPayableCurrent`	-	USD	Point-in-time
Interest payable	`InterestPayableCurrent`	$1.06K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$54.17K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$25.69K	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$15.00K	USD	Point-in-time
Interest Payable	`InterestPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Interest Payable	`InterestPayableCurrentAndNoncurrent`	$782.00	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$15.78K	USD	Point-in-time
Total Liabilities	`Liabilities`	$54.17K	USD	Point-in-time
Total Liabilities	`Liabilities`	$41.47K	USD	Point-in-time
Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Series A, Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,731,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,731,200 and 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.07K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.14M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.17M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.19M	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$47.48K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-44.08K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$10.10K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$279.00	USD	Point-in-time

Income Statement 15 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$13.04K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$22.88K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.19M	USD	11 Qtrs
Net loss	`NetIncomeLoss`	$-13.04K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.19M	USD	11 Qtrs
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-22.88K	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	11 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.46M	shares	11 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	1 Quarter

Cash Flow Statement 41 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-13.04K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.19M	USD	11 Qtrs
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-22.88K	USD	1 Quarter
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	1 Quarter
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	1 Quarter
Stock issued for services - related parties	`ShareBasedCompensation`	$1.07M	USD	11 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableTrade`	$34.17K	USD	11 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableTrade`	-	USD	1 Quarter
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableTrade`	$12.70K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.04K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.18K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-81.46K	USD	11 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from notes payable	`ProceedsFromNotesPayable`	$20.00K	USD	11 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$15.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$71.56K	USD	11 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$20.00K	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$15.00K	USD	1 Quarter
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$91.56K	USD	11 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.00K	USD	1 Quarter
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$10.10K	USD	11 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$9.82K	USD	1 Quarter
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.96K	USD	1 Quarter
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.71K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.10K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.71K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$279.00	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.10K	USD	Point-in-time
Income Taxes	`IncomeTaxesPaid`	-	USD	11 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	11 Qtrs
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Stock issued for services - related parties, Value per share	`StockIssuedForServicesRelatedPartiesFairMarketValue`	$0.05	USD	2 Qtrs
Stock issued for cash, Minimum fair market value	`StockIssuedForCashMinimumFairMarketValue`	$0.01	USD	2 Qtrs
Stock issued for cash, Maximum fair market value	`StockIssuedForCashMaximumFairMarketValue`	$0.05	USD	2 Qtrs
Stock issued for cash, Value per share	`StockIssuedForCashFairMarketValue`	$0.20	USD	1 Quarter
Beginning balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-44.08K	USD	Point-in-time
Stock issued for cash	`StockIssuedDuringPeriodValueIssuedForCash`	$20.00K	USD	1 Quarter
Stock issued for cash	`StockIssuedDuringPeriodValueIssuedForCash`	$50.98K	USD	2 Qtrs
Receipt of subscription receivable	`StockholdersEquityOther`	$575.00	USD	Annual
Net loss	`NetIncomeLoss`	$-13.04K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.45K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.19M	USD	11 Qtrs
Net loss	`NetIncomeLoss`	$-49.80K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-22.88K	USD	1 Quarter
Balance	`StockholdersEquity`	$-1.75K	USD	Point-in-time
Balance	`StockholdersEquity`	$47.48K	USD	Point-in-time
Balance	`StockholdersEquity`	$-41.19K	USD	Point-in-time
Balance	`StockholdersEquity`	$-44.08K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.